Medtronic Revenue 2010-2024 | MDT
Medtronic annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Medtronic revenue for the quarter ending October 31, 2024 was $8.403B, a 5.25% increase year-over-year.
- Medtronic revenue for the twelve months ending October 31, 2024 was $32.996B, a 3.25% increase year-over-year.
- Medtronic annual revenue for 2024 was $32.364B, a 3.64% increase from 2023.
- Medtronic annual revenue for 2023 was $31.227B, a 1.45% decline from 2022.
- Medtronic annual revenue for 2022 was $31.686B, a 5.21% increase from 2021.
| Medtronic Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $32,364 |
| 2023 | $31,227 |
| 2022 | $31,686 |
| 2021 | $30,117 |
| 2020 | $28,913 |
| 2019 | $30,557 |
| 2018 | $29,953 |
| 2017 | $29,710 |
| 2016 | $28,833 |
| 2015 | $20,261 |
| 2014 | $17,005 |
| 2013 | $16,590 |
| 2012 | $16,184 |
| 2011 | $15,508 |
| 2010 | $15,392 |
| 2009 | $14,599 |
| Medtronic Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-10-31 | $8,403 |
| 2024-07-31 | $7,915 |
| 2024-04-30 | $8,589 |
| 2024-01-31 | $8,089 |
| 2023-10-31 | $7,984 |
| 2023-07-31 | $7,702 |
| 2023-04-30 | $8,544 |
| 2023-01-31 | $7,727 |
| 2022-10-31 | $7,585 |
| 2022-07-31 | $7,371 |
| 2022-04-30 | $8,089 |
| 2022-01-31 | $7,763 |
| 2021-10-31 | $7,847 |
| 2021-07-31 | $7,987 |
| 2021-04-30 | $8,188 |
| 2021-01-31 | $7,775 |
| 2020-10-31 | $7,647 |
| 2020-07-31 | $6,507 |
| 2020-04-30 | $5,997 |
| 2020-01-31 | $7,717 |
| 2019-10-31 | $7,706 |
| 2019-07-31 | $7,493 |
| 2019-04-30 | $8,146 |
| 2019-01-31 | $7,546 |
| 2018-10-31 | $7,481 |
| 2018-07-31 | $7,384 |
| 2018-04-30 | $8,144 |
| 2018-01-31 | $7,369 |
| 2017-10-31 | $7,050 |
| 2017-07-31 | $7,390 |
| 2017-04-30 | $7,916 |
| 2017-01-31 | $7,283 |
| 2016-10-31 | $7,345 |
| 2016-07-31 | $7,166 |
| 2016-04-30 | $7,567 |
| 2016-01-31 | $6,934 |
| 2015-10-31 | $7,058 |
| 2015-07-31 | $7,274 |
| 2015-04-30 | $7,304 |
| 2015-01-31 | $4,318 |
| 2014-10-31 | $4,366 |
| 2014-07-31 | $4,273 |
| 2014-04-30 | $4,565 |
| 2014-01-31 | $4,163 |
| 2013-10-31 | $4,194 |
| 2013-07-31 | $4,083 |
| 2013-04-30 | $4,460 |
| 2013-01-31 | $4,027 |
| 2012-10-31 | $4,095 |
| 2012-07-31 | $4,008 |
| 2012-04-30 | $4,297 |
| 2012-01-31 | $3,918 |
| 2011-10-31 | $4,023 |
| 2011-07-31 | $3,946 |
| 2011-04-30 | $3,975 |
| 2011-01-31 | $3,857 |
| 2010-10-31 | $3,903 |
| 2010-07-31 | $3,773 |
| 2010-04-30 | $3,770 |
| 2010-01-31 | $3,851 |
| 2009-10-31 | $3,838 |
| 2009-07-31 | $3,933 |
| 2009-04-30 | $3,829 |
| 2009-01-31 | $3,494 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $119.009B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.537B | 27.97 |
| Boston Scientific (BSX) | United States | $156.388B | 42.28 |
| Stryker (SYK) | United States | $146.977B | 31.60 |
| EssilorLuxottica (ESLOY) | France | $141.159B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.863B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.958B | 28.56 |
| GE HealthCare Technologies (GEHC) | United States | $42.167B | 20.54 |
| Agilent Technologies (A) | United States | $38.420B | 25.46 |
| ResMed (RMD) | United States | $34.217B | 26.35 |
| Terumo (TRUMY) | Japan | $26.961B | 38.34 |
| Koninklijke Philips (PHG) | Netherlands | $26.497B | 20.28 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.011B | 12.56 |
| Insulet (PODD) | United States | $19.680B | 78.37 |
| Baxter (BAX) | United States | $15.736B | 10.24 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.236B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.837B | 36.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.760B | 26.88 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $4.260B | 20.33 |
| ICU Medical (ICUI) | United States | $3.921B | 37.33 |
| Envista Holdings (NVST) | United States | $3.723B | 29.62 |
| Perrigo (PRGO) | Ireland | $3.341B | 9.84 |
| Haemonetics (HAE) | United States | $3.133B | 14.74 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.963B | 19.97 |
| QuidelOrtho (QDEL) | United States | $2.729B | 22.92 |
| LeMaitre Vascular (LMAT) | United States | $2.218B | 53.91 |
| Neogen (NEOG) | United States | $2.133B | 24.58 |
| AtriCure (ATRC) | United States | $1.996B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.528B | 26.67 |
| InMode (INMD) | Israel | $1.308B | 10.94 |
| BioLife Solutions (BLFS) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.181B | 8.44 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.061B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.044B | 16.01 |
| Curaleaf Holdings (CURLF) | Canada | $0.978B | 0.00 |
| Evolus (EOLS) | United States | $0.933B | 0.00 |
| CeriBell (CBLL) | United States | $0.768B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.725B | 0.00 |
| Owens & Minor (OMI) | United States | $0.574B | 4.49 |
| VAREX IMAGING (VREX) | United States | $0.547B | 23.70 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Omeros (OMER) | United States | $0.532B | 0.00 |
| SNDL (SNDL) | Canada | $0.489B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.56 |
| Aurora Cannabis (ACB) | Canada | $0.346B | 63.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.346B | 0.00 |
| Cerus (CERS) | United States | $0.344B | 0.00 |
| Quanterix (QTRX) | United States | $0.310B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 29.00 |
| Canopy Growth (CGC) | Canada | $0.294B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.293B | 19.65 |
| Biote (BTMD) | United States | $0.249B | 5.45 |
| Zynex (ZYXI) | United States | $0.240B | 50.27 |
| INLIF (INLF) | $0.237B | 0.00 | |
| Sanuwave Health (SNWV) | United States | $0.229B | 3.21 |
| High Tide (HITI) | Canada | $0.214B | 0.00 |
| Brainsway (BWAY) | Israel | $0.213B | 113.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 15.46 |
| TerrAscend (TSNDF) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| MacroGenics (MGNX) | United States | $0.161B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.135B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 11.61 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.060B | 30.83 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.053B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.32 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |